Most Pioneering Healthcare Solution Providers | Thyrocare

2020/Vol.03/Issue-01
ASIA'S
10
PioneeringHEALTHCARE SOLUTION PROVIDERS 2020
MOST
Dr. A. Velumani
Founder
“Being in the healthcare
industry, it is the patient
who is both our primary
customer and concern
“

employment sector into one scheme. Not only it covers
the entire nation or territory in the said package, but also
enhances equity in the overall healthcare system. Still, if
countries can successfully implement universal social
healthinsurancedepends onanumber ofpreconditions.
Particularly, the level of economic development of the
country defines the efforts of implementation of the
same.
A country’s stage of economic development
determines its availability of resources for healthcare
system financing no matter where it finances from. The
source of financing can be through general government
tax revenue or contributions from households,
employees, and employers, etc. To reach wide coverage
when a nation particularly has a large informal
employmentsector,thetraditionalformsofsocialhealth
insurancearenotfeasibleoptions.Thisismainlybecause
they depend on contributions from employees and their
respectiveemployers.
The traditional methods of social health insurance
procure premiums by direct payroll deductions and
without formal wage records, collections from the
informal sector by default renders a voluntary process
even if they are mandated by design. What could
potentially threaten the financial sustainability of the
program are the people who voluntarily enroll and have
considerable health issues, leading to problems of
adverse selection. That is the reason there is a necessity
forintegratedhealthcaresystemsinAsia.
Asia requires efficient health systems with integrated
care as there is a rapidly aging population along with the
rising burden of patients with chronic conditions. Even
thoughtherehavebeeneffortstointegrateprimary
Need of an Integrated
Healthcare System in Asia
DARSHAN PARMAR
Asia is a diverse continent. In some of the
countries in east and Southeast Asian sub-
regions, the stages of demographics, economic
development, and epidemiological profiles are quite
heterogeneous. It is observed that there is a
convergence towards universal social health insurance
as the primary health system architecture in Asia. An
identical benefit package is the attraction of universal
social health insurance which amalgamates government
subsidies and contributions from employees,
employers, and external individuals from the formal

Editor’s Note
care and critical care in Asia, but the overall care delivery
system remains quite fragmented. The primary health
care system needs robust and effective initiatives that
are targeted towards speciﬁc diseases such as
hypertension, diabetes, dementia, and depression.
These are some of the common chronic conditions that
requireimmediateattention.
Allofthiscanbeachievedthroughahealthcaremodelof
collaborative care provision, which is an integrated care
approach. The key stakeholders of this approach need
to have a thorough understanding of the high-risk
patient demographics and suitable resources to
confront the imminent population dynamics, especially
the shifts due to extremely rapid rate of increase in the
aging population of Asia. This is to ensure the successful
implementationofintegratedcarepolicy.
Through this month’s edition, ‘Asia’s 10 Most
Pioneering Healthcare Solution Providers 2020’,
Insights Care wishes to highlight some of the companies
that are working with a differentiated approach aligned
withtheintegratedcarepolicyinAsia.
On the cover of the magazine, we have Thyrocare, an
organization with a vision to achieve quality health for a
betterworld.
Intheclusterofstories,themagazineincludesagroupof
software developers working at Origin Integrated
Studios who are working to make a positive difference
while developing innovative and creative healthcare
application software solutions. Other than this, there is
an organization that maintains a certain ubiquity of its
technology throughout the healthcare domain and is a
leadingbiotechnologycompany.Bioneerisonamission
to become a prominent solution provider in healthcare
technologies. Cover2Protect is a start-up platform and
convergence of digital world, modern medicine, and
Ayurveda. It is on a mission to transform the future of
healthcare delivery across the world. Another company
that is making a difference in the healthcare domain is
Lifetrack Medical Systems. It is a company that is
makinghealthcaresoftware,morehuman.Theﬁnalstory
in the list is of V2U Healthcare. The company has been
spreading its wings to provide innovative Physiotherapy
RehabilitationandElectrotherapyequipment.
There are also some honorable mentions in this edition,
companies that are playing an integral role in facilitating
distinguished products/services related to healthcare in
their own way. Names such as AUM Biosciences,
Adagene, AFT Pharmaceuticals, and Huami
Technology are certainly proving to be remarkable
contributorsintheAsianhealthcaredomain.
In an exclusive interview with Insights Care, AdAlta is
informing us, how it is using its powerful technology
platform to generate a promising new class of single
domain antibody protein therapeutics which have the
potential to treat some of today’s most challenging
medical conditions. Also, this issue of the magazine also
portrays Charles Bark’s CXO standpoint titled
‘Healthcare: The Future of Ageing’. He is the Founder
andCEOofHiNounou.
Insights Care’s team urges its readers to sit back, relax
and read away all the incredible stories that these
amazing healthcare solution providers are trying to
convey.
Darshan Parmar

POWERINGTHEHEALTHCAREENGINEWITHAUTOMATION
Interview
16
AdAlta
A New Paradigm of
Therapeutic Antibodies
34
Expert Valuation
Healthcare: the
Future of Ageing
22
Editor’s Insights
Cloud Technology
Transforming Healthcare
Sector
CXO Article
Cover Story
08

Bioneer
A Compassionate and Trusted
RNAi Therapy Provider
Cover2Protect
A Compassionate and Trusted
Telehealth Provider
Lifetrack Medical Systems
Making Healthcare Software
Human
Origin Integrated Studios
Offering Conclusive Technical
Solution For Healthcare
V2U Healthcare
Setting Benchmarks in
Physiotherapy and
Rehabilitation Care
20
26
30
38
42
CONTENTS
MARCH
2020

Co-designer Paul Belin
Art & Picture Editor Asha Bange
Art & Design Head Amol Kamble
Editor-in-Chief Pooja M. Bansal
Managing Editor Rajkunwar Bhosale
Senior Editor Anish Miller
Visualiser David King
Poonam MahajanArt & Design Assistant
Circulation Manager Tanaji
Research Analyst Eric Smith
Mark WilliamsBusiness Development Executive
Peter CollinsBusiness Development Manager
Sales Executives Kelli, Sarah, Bill, John, Amy
SME-SMO Executives Uma, Gemson
Digital Marketing Manager Alina Sege
Technical Consultants David, Robert
Technical Head Jacob Smile
Marketing Manager Marry D’Souza
Assistant Technical Head Pratiksha Patil
Assistant Digital Marketing Manager Prashant Chevale
Copyright © 2020 Insights Success Media and Technology Pvt. Ltd., All rights reserved. The content and images used in this magazine should not be reproduced or
transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission from Insights success.
Reprint rights remain solely with Insights Success Media and Technology Pvt. Ltd. Insights Care is powered by Insights Success Media and Technology Pvt. Ltd.
March, 2020
Follow us on : www.facebook.com/InsightsCare/ https://twitter.com/Insightscare
Insights Success Media Tech LLC
555 Metro Place North, Suite 100,
Dublin, OH 43017, United States
Phone - 302-319-9947
Email: info@insightscare.com
For Subscription: www.insightscare.com
Insights Success Media and Technology Pvt. Ltd.
Ofﬁce No. 22 & 510, Rainbow Plaza, Shivar Chowk,
Pimple Saudagar, Pune, Maharashtra 411017
Phone - India: 7410033802, 74100058552
Email: info@insightscare.com
For Subscription: www.insightscare.com
Publishing Control Team Shruti Jambhale
Quality Assurance Team Abhishaj, Sneha, Darshan
sales@insightscare.com
Corporate Ofﬁces:

POWERINGTHEHEALTHCAREENGINEWITHAUTOMATION
THYROCARE HAS MADE
RIGHT USE OF THE
ADVANCED SUPERIOR
TECHNOLOGY, CAPABLE
OF WORKING ON ITS
UNBELIEVABLE VOLUMES
AND YET DELIVER QUALITY
AND PRECISION TO
ITS CUSTOMERS
“
“

Medical diagnostics is at the centre of healthcare
delivery. In recent years, much has been said
about process improvement and automation and
how can these approaches help medical diagnostic centres
improve efficiency and cut costs.
Equally significant is their ability to reduce the opportunity
for medical errors and increase patient safety. Laboratories
produce test results that are widely used in clinical and
public health settings. They affect the treatment decisions in
as many as 70% of medical cases. The patients health
outcomes depend on the accuracy of testing and reporting.
Thus, delayed or incorrect laboratory results caused by poor
sample quality or other pre-analytical factors potentially
obstruct or lead to erroneous diagnosis and treatment. This
may impact patient outcomes, severely compromising
patient safety leading to unintended economic burden on
the laboratory or the hospital.
In order to achieve the highest level of accuracy and
reliability, it is essential to replace the existing systems and
incorporate such systems that can efficiently perform all
processes and procedures in the laboratory.
Studies say that such errors or delays contribute to millions
of injuries and deaths every year. Having intensified efforts
to combat this serious problem, many laboratory
professionals and hospital administrators have come into
force at implementing automation systems in their clinical
laboratories. As automation continues to grow in popularity,
these laboratories are witnessing the proof of its success
and tapping into dramatic improvements in error reduction
and testing efficiency.
Witnessing the benefits of automation, laboratories have no
doubt grown more enthusiastic about improving processes
through automation. This has demonstrated the fact that
laboratories play a cardinal role in safeguarding the well-
being of patients. Notably, automation is a tool that enables
the professionals to perform this role much more efficiently
and effectively.
An organization achieving the vision of quality health for a
better world which is at the forefront of innovation in the
healthcare industry is, Thyrocare Technologies Limited. It
is proud to be a part of the technology and automation shift
that is transforming the medical and healthcare landscape.
At the Forefront of Automation
The Mumbai headquartered organization Thyrocare, is a
diagnostic laboratory that is focused on clinical chemistry.
It operates across ten countries and processes nearly
4,00,000 tests related to various disorders per day.
Thyrocare is India’s first and most advanced fully
automated laboratory having a strong presence in more than
2000 cities and towns across India and the globe. It
primarily focuses on providing quality services at
affordable costs to laboratories and hospitals in India and
other countries.
Thyrocare plays an active role in supporting small
laboratories that lack costly analysers to fulfil their
diagnostic needs using a back end high technology partner.
It provides cutting edge solutions to chronic illnesses
offering affordable and reliable solution in identifying,
monitoring and managing the disorder.
The Journey of a Prolific Entrepreneur
Dr. A. Velumani, the Founder of Thyrocare, was born in
Appanaicken Patti Pudur, in 1959, a small village in the
outskirts of Coimbatore District, Tamil Nadu. Regardless of
being born to an underprivileged family, his mother
managed to admit Dr. A. Velumani and his siblings to
pursue graduation from the Chennai University.
Dr. A. Velumani, after completing graduation, along with
his siblings, managed to accomplish post graduation from
the Mumbai university by barely earning money to survive.
The dearth of job opportunities available in Coimbatore
required him to move to Mumbai in 1982. Putting immense
efforts, he finally got recruited to Bhabha Atomic Research
Centre in Mumbai. To his surprise, getting admitted to
BARC was as if a dream come true. Apparently, at the
centre, he completed PhD in Thyroid Biochemistry during
his stint of 14 years at BARC as a Research Scientist.
By the time he was 37 he had accomplished all the desires
anyone would dream for- Job, Salary, Caring wife,
Children, Comfort, and Luxury. But still, something kept
him bothering. It made him feel that this is a high time in
QUALITY IS NEVER AN
ACCIDENT; IT IS ALWAYS
THE RESULT OF HIGH
INTENTION, SINCERE EFFORT,
INTELLIGENT DIRECTION
AND SKILLFUL EXECUTION
“
“

HYROCARE’S
CLEAR FOCUS IS
TO FACILITATE
AND STANDARDIZE
QUALITY AND COST
OF LABORATORY
SERVICES ACROSS
THE WORLD
“
“

instrumentation. Its uniqueness is looked upon as a
yardstick for quality by stakeholders in the diagnostic
industry. Its effort to innovate and remain at par of the
global standards for best of quality service delivery, at the
most cost-effective prices sets it apart.
Smart Solutions
Thyrocare was a 100% manual laboratory conducting all
the tests using trained manpower from the year 1995 to
2000. It scaled its operations and by 2010 it carried out 90%
automated procedures. It has integrated Total Laboratory
Automation (TLA) to improve productivity of machines
and workforce. The installation of ‘Aptio system’ by
Siemens has made the entire operations seamless and totally
automated.
It has created an in-house IT solution, called ‘Charbi’
previously known as ‘Back Bone’ which today seamlessly
connects employees, departments, franchisees, DSAs and
vendors as well. Its robust IT infrastructure connects its
network of clients spread across ten countries to its Cloud
Server. The cloud server is an integration of Laboratory,
Technology, Business, Logistics, CRM and administration.
Thyrocare has also partnered with ‘Better-Life’ for
customer convenience. Better-Life, is a mobile app
development company specialising in the healthcare sector.
It works to bring mobility into the diagnostic services space
by giving customers the convenience to book tests, view
reports and check health notifications on their mobile
devices.
Comprehending the Future
Thyrocare aims to focus more on the same domain i.e.
clinical chemistry, which has huge scope globally. It
envisions to add more technologies in clinical chemistry,
and add more tests in it for menu expansion. It looks
forward to introduce more packages for preventive care,
more franchisees and reach the far flung and smaller towns
in India.
his life where he can take risks and do something impactful.
By taking some life changing decisions, he and his wife
gathered huge amount of funds and established Thyrocare.
The journey of good and bad experiences had curated and
transformed his life which made him what he is today, a
Prolific Entrepreneur.
Utilizing his 15 years knowledge of Thyroid Biochemistry
and its testing methods, technology and reagent
manufacturing Dr. A. Velumani disrupted the traditional
business models in clinical chemistry. And now Thyrocare,
his venture, has reached a 3000 crore market capitalisation
in a period of 20 years. Thyrocare has so far employed 8000
graduates and is directly or indirectly providing livelihood
to over 10,000 families.
A Historic Feat in Clinical Chemistry
Initially, Thyrocare had started with a focus on Thyroid
made Thyroid volumes. It helped Thyrocare to build a
foundation for HR management, IT, and Logistics that
would handle operations in multiple cities.
In the following years, Dr. A. Velumani along with his team
of professionals from the medical fraternity, incorporated
clinical operations for Infertility, Pregnancy, Growth and
Metabolism, Diabetes, and Oncology. Currently, Thyrocare
works on conducting 300 different tests through its
automated laboratory. It’s focus is on metabolism.
Considering the use of technology, during the initial phases,
it used only a single technology ‘Radioimmunoassay’. Its
focus on speed and accuracy made Thyrocare the first
Indian laboratory to boast of an IT enabled and fully
automated diagnostic laboratory before it actually emerged
in practice all over the country.
Today, Thyrocare is the single most fully automated
laboratory in India with an investment of around 100 crores
on analysers and automation. Serving best to the
community it has made a big difference to the country
through its clinical research and by introducing advanced
technologies to work efficiently.
Moreover, it is the first company in India to introduce
barcoding system at collection point. It provides collection
kits, which contains barcoded tubes and consumables and
ensures that error free samples are collected.
It is equipped with meticulously created and monitored
systems, well-chosen and trained manpower, best global
technologies for testing and an uncompromised approach to
THE UNIQUENESS OF
THYROCARE IS ITS EFFORT
TO INNOVATE AND REMAIN
AT PAR OF THE GLOBAL
STANDARDS FOR BEST OF
QUALITY SERVICE DELIVERY,
AT THE MOST COST-
EFFECTIVE PRICES
“
“
ASIA'S
10
MOST

SUBSCRIBE
TODAY
Never Miss An Issue
Stay in touch.
Subscribe to Insightscare Get Insightssuccess
Magazine in print, & digital on www.insightscare.com
Check should be drawn in favor of :
INSIGHTS SUCCESS MEDIA TECH LLC
www.insightscare.com

Dr Tim Oldham
CEO
16 | March 2020 | www.insightscare.com

veryday we come into contact with several form of
Ebacteria, viruses and other disease causing organisms.
However we don’t fall ill every other day which is due
to our immune system. An army of cells is always present in
our body to fight against the invading particles. And,
antibodies are the crucial bodies of the immune system helping
us fight off nasty invading particles.
AdAlta Limited (ASX:1AD), a highly innovative drug
discovery and development organization, is using its powerful
technology platform to generate a promising new class of
protein therapeutics known as i-bodies, that have the potential
to treat some of today’s most challenging medical conditions.
AdAlta is a late pre-clinical stage, ASX-listed Biotechnology
company. AdAlta was founded 12 years ago to develop and
commercialize intellectual property developed by an academic
collaboration known as the Cooperative Research Centre for
Diagnostics (CRC’s have been a very productive Australian
initiative for driving translational research to commercial
outcomes).
This intellectual property derived from the discovery that the
immune system of sharks includes a novel class of single-
domain antibodies with unique properties that enable them to
bind and access receptors that traditional antibodies cannot.
The additional discovery of human protein scaffolds with very
similar structures enabled AdAlta to create libraries containing
billions of proprietary i-bodies: human single-domain
antibodies that incorporate the advantages inspired by shark
immune systems.
The unique advantage of i-bodies is their ability to bind
complex receptors very specifically and with very specific and
selective pharmacology, something that small molecule drugs
and antibodies are often unable to do. This enables AdAlta to
“drug difficult to drug targets”. A particular field of interest is
the very large family of receptors called G-protein coupled
receptors (GPCRs) that are targets for almost half the approved
drugs today but which have very complex pharmacology,
meaning that even if they can be successfully drugged, this is
often at the expense of serious side effects.
AdAlta spent its early years proving the unique properties of
its i-bodies, building libraries of i-body variants and
developing methods of screening the libraries against
therapeutically interesting targets.
One of these, i-body against a GPCR called CXCR4, is being
developed as an anti-fibrotic drug and the company has spent
significant efforts generating proof about the concept of pre-
clinical data in several fibrotic disease models. In 2016, AdAlta
listed itself on ASX to raise funds necessary to progress this
lead product, AD-214, towards clinical trials, something the
Company hopes to initiate in 2020.
In an interview with Insights Success, Dr. Tim Oldham, the
CEO of AdAlta shares insightful perspectives and opinions
AdAlta
A New Paradigm
of Therapeutic
Antibodies
Dr Tim Oldham became CEO of AdAlta in October 2019. He has more than 20-years of
experience developing strategies and building businesses in pharma companies and biotechs in
Europe and Asia. He sees an opportunity to leverage the “coming of age” moment for any platform
company that is getting its rst product into clinical trials to accelerate the growth of the company
and signicantly expand its pipeline. He feels, it requires continued focus on delivering lead product
candidate AD-214 into clinical trials in mid-2020; development of target selection processes to
make smart choices about new products to add to the pipeline; and expanding the product pipeline
through internal and partner programs. He believes, this of course requires additional funding and
linking the new, expanded vision for AdAlta with an achievable operating strategy and a nancing
strategy that continues to build value for existing and new shareholders with a key objective.
ABOUT THE LEADER
17| March 2020 |www.insightscare.com

about the organization, its vision and mission, its key aspects,
and how it strives towards a better tomorrow for its therapeutic
discoveries.
Below are the highlights of the interview:
IS: What are the pioneering healthcare solutions your
company caters to.
AdAlta’s i-body platform has unique capabilities for drug
development. We have focused difficult to drug targets where
traditional small molecule and antibody technologies have not
been able to deliver optimal therapeutic outcomes. AD-214 is
being developed to improve outcomes for fibrotic disease.
AdAlta’s innovation has been to discover i-body that can block
CXCR4’s fibrotic signaling, but not affect stem cell
mobilisation, making it a potential first-in-class drug for IPF
and fibrotic diseases. We aim to progress AD-214 into clinical
trials in mid-2020.
IS: What are your major threats and challenges? What has
been your strategy to overcome these?
Drug development, particularly biological drug development,
has very high rewards when it is successful, but is a risky and
expensive process. Financing such programs is always a
challenge and we’ve been very fortunate to attract some high-
profile, patient investors in our company to date.
Our scale is also a challenge - today we are critically
dependent on success of a single product, AD-214, and
diversifying the pipeline to reduce risks (though this increases
cash requirements in the near term).
Addressing these challenges requires a very clear strategy for
the pipeline, patient investors aligned with the strategy, great
execution and biology that delivers the hoped-for outcome. We
can control all but the last and this then is the focus of the
leadership team.
Unfortunately, biology does not always behave as expected or
hoped for. For example, AdAlta changed the format of its lead
i-body just prior to moving it into clinical trials and this
required repeating significant manufacturing and pre-clinical
work. Whilst that affected our original clinical program
timeline, we made the decision to transition as AD-214 retains
the unique therapeutic benefits of AD-114 but delivers
enhanced activity and significantly improved half- life. AD-
214 is also expected to be more attractive to patients and
potential pharma partners.
IS: Kindly elaborate the company’s major
accomplishments? Please mention any awards or accolades
received so far, if any.
In the past year, AdAlta has successfully completed a Good
Laboratory Practice (GLP) non-human primate toxicology
study to evaluate safety and toxicology of AD-214, an essential
pre-requisite to initial human studies.
We successfully completed AD-214 cell-line and
manufacturing process development and completed
manufacturing of clinical (GMP grade) AD-214 bulk drug
substance. And we were awarded a Biotechnology
Translational Bridge (BTB) program grant from the Australian
Medical Research Futures Fund (MRFF) to develop a
radiolabeled PET imaging agent version of AD-214. It will
significantly enhance the information we can obtain about AD-
214 through initial human studies
On the partnership front, we entered a partnership with GE
Healthcare to develop pre-clinical targets for diagnostic
imaging and received our first ever partnering revenue. We
also entered a collaboration with UK-based research
organisation, Excellerate Biosciences to identify i-bodies with
unique efficacy, safety and duration and determine which ones
are best-in-class for binding to drug targets, specifically G
protein-coupled receptors (GPCRs).
AdAlta was named as a finalist in the Australian Technologies
Competition in 2018 and last year, was named as a Company
to Watch in the ANZLF Trans-tasman Innovation and Growth
Awards.
IS: Kindly brief us about your perspective on the current
healthcare industry scenario in Asian countries.
Asia’s healthcare industry is at an exciting stage. Ten years
ago, it was regarded as a second- or third-tier market where
local players were largely copiers of western drugs. The
markets have now matured significantly, both in quality of an
access to healthcare (so that Asia and China in particular are
now high on everyone’s partnering list) and local innovation.
We have also seen Japanese pharma increasingly globalise.
IS: Where do you see the company in the coming years?
What actions have you planned for the same?
AdAlta’s mission is to develop multiple i-body based drugs
against difficult to drug targets from its platform to address
substantial unmet needs. It will use its coming of age as a
clinical stage biotech company to accelerate and expand the
level of activity on its two revenue streams: development of
carefully selected internal product candidates into clinical
proof of concept prior to licensing to big pharma (more AD-
214’s); and developing more partnerships where we co-
develop drugs from our platform against targets brought to us
by partners (more GE-like deals).
IS: Kindly enlighten the upcoming generation of medical
science enthusiasts and health-tech entrepreneurs?
Biotech and health technology are not for the faint hearted
people. You need persistence, resilience and access to great
mentors and advisers. Above all, it is really important to start
with the end in mind: what product will customers (usually
governments or insurers) pay for. I see too many elegant
technical discoveries that are not being developed into a useful
product because there has not been a consideration of what
partners and customers will actually pay for.

With the least amount of speculations and
ambiguity, we can effortlessly say, “It is a good
time to be alive.” The context here, is of the
radical development we’ve witnessed in the Healthcare
discipline over the past few decades.
From manual surgeries to use of robotics, from invasive
diagnosis and treatment to Nanomedicine, and from visiting
the doctor to leveraging the Telehealth approach, everything
we know about healthcare is changing. The implicit
technological revolution and its consensual acceptance has
played a vital role in bringing about this positive change.
As much ‘good time’ it is for the common public, so it is for
healthcare providers and organizations functioning in the
same sector. Advantages of a relatively less-explored arena
and probably laying the cornerstones of a new revolution
simultaneously, are the possibilities that the healthcare
sector has to offer.
A number of organizations have created a foothold in the
healthcare domain, have evidently leveraged these offerings
and have also ceaselessly striven to deliver game-changing
technologies, products and services.
One among these organizations, which maintains a certain
ubiquity of its technology throughout the healthcare domain
is Bioneer, a leading biotechnology company with a
mission to become a preeminent solution provider in
contemporary and reformative healthcare technologies.
A Strong Foundation
Bioneer, since its inception in 1992, is being steered
towards pinnacles of global success by Dr. Han-Oh Park,
the Founder, President and CEO. He founded Bioneer
Corporation in 1992 with oligonucleotide and enzymes for
PCR and genetic engineering. He has also invented
hundreds of technologies and instruments for the
acceleration of the genomics revolution.
“When I started Bioneer, I had been experiencing the
revolution of genetic engineering. In 1992, I founded
Bioneer as a first biotech in Korea to be a Bio-Pioneering
and Bio-engineering company,” Dr. Park expresses.
Bioneer envisions blazing the biotechnology trail as a
pioneer, and delivering the value to people through genetic
technologies. In order to achieve the goal, Dr. Park has
invested 30-40% of revenue into R&D and developed and
commercialized the essential instruments and reagents for
molecular biology such as DNA synthesis, sequencing,
PCR and RNAi, which aided the company to
commercialize four Nobel prizes in Science.
Dr. Park is a graduate from the Dept. of chemistry, SNU.
He started the research on DNA synthesis in the KAIST and
had been a researcher in the molecular biology lab of
KRIBB until 1992. His leadership as an innovator of the
company has positioned the company as a ‘Bioneering
company’ for future healthcare innovation.
Exemplifying Excellence
Bioneer developed the real-time qPCR first in Asia. During
the swine flu pandemic, it developed the first H1N1
diagnostics kit and automated molecular diagnostics
™
system, ExiStation . The company supplied 2.5 million test
kits to the Korean hospital and government healthcare
centre, which made the doctors possible to prescribe
®
Tamiflu after diagnosis only in Korea.
The company also started an anti-obesity microbe project in
1999 by drawing inspiration from the controlling of energy
uptake through the gut microbe. Lactobacillus Gasseri
®
BNR17 was discovered from human breast milk and
developed and approved as the first body-fat-lowering
probiotics from Korean MFDS.
Bioneer established a subsidiary company, AceBiome Inc.
to focus on microbiome business. It was licensed to UAS
lab in U.S. and got the 2018 NutraIngredients-USA award
®
in weight management. BNR17 is very successful in the
market and AceBiome is growing at a CAGR > 600 % since
2017.
Surpassing Challenges
Bioneer started with genetic technology and continuously
expanded its product offerings in molecular research
products which are applicable to next-generation
diagnostics and therapeutics. It expanded its R&D to
BIONEERA Compassionate and Trusted RNAi Therapy Provider

molecular diagnostics and RNAi therapeutics since 2001 after raising
a funding of 25 million.
The company is very competitive in both areas, as it has accumulated
experiences and high-throughput infrastructure to run R&D
efficiently with its products. Nevertheless, the R&D budget is too
huge to do developments only with limited capital, especially in the
clinical development of various indications for the blockbuster
siRNA therapeutics.
In order to avoid a cash burnout in clinical developments, Dr. Park
established a subsidiary company siRNAgen Therapeutics to
accelerate the clinical development of innovative drugs. “We have
™
developed a wide range of anti-fibrosis drug, Amphisiran with
™
SAMiRNA (Self-Assembled Micelle inhibitory
RNA) platform technology,” he adds.
Ascending Zeniths
In the year 2000, Bioneer developed a 384-parallel
DNA synthesizer which was the highest
throughput. The company started fission yeast
genome knock-out project to explore every
essential genes in cell division, finally completed
the S.pombe genome knock-out library and
identified key genes in the cell division.
Bioneer also invented the high throughput protein
synthesizer, called Exiprogen™ which makes more
than 90 % pure proteins from template DNA made
by PCR reaction within 6 hours. By combining
Exiprogen™ with gene synthesis technology, it
will accelerate the BIO 2.0 revolution in post-
genomic era.
Upon the Ebola outbreak, Bioneer collaborated
with the Nigerian government (NABDA) and
delivered the Ebola diagnostic kits for the earlier
diagnosis of the patients. Additionally, during the
outbreak of ZIKA, the company developed the first
ZIKA multiplex kit (Dengue, chikungunya) and
got the first approval of WHO EUAL. Bioneer is
the first Asian molecular diagnostics company
which has CE-IVD of HIV and HCV viral load kits
with their own molecular diagnostic platform.
Bioneer is also the first supplier of the genome-
wide siRNA library in Asia. In order to develop
next-generation RNAi therapeutics platform, the
company invented novel therapeutic siRNA
™
nanoparticle called SAMiRNA which overcame
the major hurdle of siRNA therapeutics.
™
SAMiRNA is free from major adverse effects like
innate immune stimulation and also deliverable to
different tissues with inflammation and neoplasia.
It also can be manufactured at a much lower cost
by its simple CMC.
TM
In 2020, Bioneer will launch the first SAMiRNA
cosmeceutical for androgenic alopecia and start the
TM
clinical trial of Amphisiran , which would be a
TM
landmark of SAMiRNA . It will also launch a
near-patient POC molecular diagnostic platform
called ‘IRON-qPCR’ which can inform about most
of infected pathogens and AMR (Antimicrobial
Resistance) within 30 min. Bioneer believes, this
will be an essential tool for precision medicine.
ASIA'S
10
MOST
Han-Oh Park
Founder, President and CEO

Transforming
HEALTHC22 | March 2020 | www.insightscare.com

CARE Sector
A
massiveshifthasbeenwitnessedinthe
generation, consumption, storage, and
sharing of healthcare data. From
conventional storage to digitalization of
healthcare data, the industry has come a long
way in optimizing its management practices.
The widespread option of moving over to cloud
computing in healthcare goes far beyond
storingdata.
Movingovertocloudhasproventobebeneﬁcial
topatientsaswellashealthcareproviders.Cloud
technology has helped hospitals, clinics, etc.
reduce operational costs while allowing
providers to deliver high quality personalized
care. The healthcare sector has evolved with the
help of cloud technology. Here are some ways
cloudhashelpedthehealthcareindustry:
Editor’s Insights

CommunicationthroughtheCloud
With a cloud-based phone system, doctors can stay
connected. There are many reasons why this type of
communication is vital today. When the doctors are
connected to each other, the communication is
reinstated and they could treat the patients better. Even
the hospitals should talk to one another every now and
then. Also they should have internal communications
within the walls of the hospital. This helps them waste
less money in developing various different methods and
go with the existing techniques. This enables the
reduction of treatment costs, as there is no cost of
discoveringwhichisalsorecoveredfromthepatients.
IntegratedandEfficientPatientCare
Managing millions of Electronic Medical Records
presents quite a challenge today. Developing
infrastructure is working hard to connect the countless
trusts, hospitals, surgeries, etc. together through the
cloud technology. Cloud computing is changing how
doctors, nurses, clinics, and hospitals deliver quality and
cost effective services. Patient care was affected during
hard times, when costs need to be cut short. Cloud
technology has offered numerous benefits like faster
prescription advice for various contemporary medical
problems.
DataAnalytics
The healthcare sector is expected to grow in
unprecedented rate in the following years. Housing the
whopping amount of data associated with it will be a big
challenge to the IT industries. The most effective
solution to this problem seems to be using the cloud
technology. Things could be made simple by making
sure the data is in the right place so it can be used at the
right time across multiple devices. Across one unified
network infrastructure, it is impossible to deliver multiple
serviceswithoutcloud.
StreamlinedCollaboration
It is said that streamlined communication results in
streamlined patient care. This is good because the
patients don’t want to be readmitted to the hospital
when they could have been taken care of the first time
itself. When the whole team is able to communicate
efficiently over cloud, readmission of the patient can be
avoided. This system allows real time updates which
make sure there are no gaps in the treatment. It saves lot
ofspaceandmoney,asthereisnoneedofsendingfiles.
ElectronicRecords
Doctors feel the lack of Electronic Medical Records
(EMR) is a big challenge to improve clinical and financial
performance. The interoperability between all the
providers and payers is hampered without EMRs. Cloud
based EMRs can easily bring healthcare systems
together. The technology provides a secure private
network that is connected to the cloud. Such records
have proven to be extremely protective. This also allows
online access of medical records, lab reports, test results
etc. to the patients. Eventually, the healthcare
experience can be improved while people participate
moreintheirtreatments.
SecurityandMobility
Patient data contains confidential information that
doctors must always protect. This is a reason that makes
it more important for hospitals and doctors to use the
cloud technology. Cloud network had issues in regards
to security earlier, but over the years measures have
been taken to make it difficult to hack into. Increased
levelsofsecurityandprivacyexistinthecloudnow.
AdvancedClinicalResearch
Sharing data between pharmaceutical giants via cloud
will help researchers choose the best subjects. In a
recent clinical trial big data revealed desipramine can be
used in curing lung cancer. This type of collecting
information to find a cure is known as Evidence Based
Medicine.Itisbeingusedinmanyhealthcaresectorsthat
havenowimplementedcloudtechnology.
-Shreevarshita Gupta

Technology has become a boon for healthcare. Using
technology to provide quicker health interventions
is soon going to become a norm. There have been
areas in which telehealth has been able to help medical
professionals. A number of healthcare professionals are
providing tele consults and many such health related
solutions.
Digitalization has allowed the patient to connect the
healthcare system easily and conveniently in a way that has
never been possible before. Its importance in countries such
as India is that startup entrepreneurs are establishing new
healthcare systems that are going to be based on
digitalization.
A startup platform and convergence of digital world,
modern medicine, and Ayurveda that is on a mission to
transform the future of healthcare delivery around the globe
is Cover2Protect(C2P).
The inspiration to start Cover2Protect was to make
healthcare personalized. It strives to uphold the power of
Modern medicine- a curative platform, and Traditional
medicine- Ayurveda, which an age old preventive measure.
Rendering Quality Medical Services
Cover2Protect believes the disease development phase
which is medically divided into six stages requires diﬀerent
intervention approaches. And Ayurveda can prevent the ﬁrst
four stages i.e. Accumulation, aggravation, Spread,
Localization. Whereas, the last two stages which is post
diagnosis i.e. manifestation and complications, modern
medicine is needed to cure it.
Cover2Protect was conceived in 2017 to help people
through personalized healthcare. It is curated based upon
the experiences of professionals from diverse backgrounds
of medical, technology and insurance.
The Vital Pillars
The founders are from diverse background like Data
Science, Medicine and Insurance. Rajat Sharma, the
Founder CEO, started C2P with the idea to build an AI
platform to make healthcare more personalized. Rajat
brings his 15 years of experience in building startups and
Cover2ProtectA Compassionate and Trusted Telehealth Provider

growing business in APAC countries to the organization.
Co-founders, Dr. Prasanna Ganappa and Nishant Gupta have
played a constructive role in building C2P a strong foundation what it
is today. Dr Prasanna is skilled in the clinical field whereas Nishant is
a seasoned entrepreneur having founded startups in Insurance and
Healthcare.
Transparency in its Work
The quality system adequately ensures the accuracy and integrity of
data to support the safety, effectiveness, and quality of the services it
delivers, and data on which it gives the personalized solutions.
The organization works closely with hospitals,
doctors, Ministry of Health and other regulators to
ensure they abide by the rules while attempting to
disrupt the way healthcare industry works. For
regulatory compliance C2P is been recognized and
awarded by various bodies in healthcare, IOT and
Artificial Intelligence space. It works with MNC
insurance companies, hospitals and government
bodies around various POCs to ensure that it has
enough feedback to analyze the data.
The Artificial Intelligence powered health
assessment platform generates a list of medical
tests based on family and personal history. The
android health applications are also a part of the
platform to communicate health tips and follow up
consultations.
Comprehensive Care
C2P is a platform that leverages AI and IOT and
data models based on Ayurveda and modern
medicine to provide a 360* view for ones personal
health insights. It aims to utilize the data (past
medical reports, HRA, Vatta-Pita-Kapha body type
analysis. It examines the behavioral data ( calories
and type of food or drinks consumed daily,
activity, travelling etc.) and make health insights
more personalized to every human body type.
It caters a wide range of wearable devices, medical
devices and KIOSK along with mobile apps that
can link up the patient or user to his or her
concerned doctor, coach or nutritionist .C2P
benefits the end user by providing enough data
points around the user to enable a seamless and
more trustworthy teleconsultation.
These services help the assessors in better
understanding the patients’ needs and expectations.
The online service platform avoids unnecessary
clinical hassles. This in turn helps in better
outcomes and increased patient satisfaction.
Accomplishments
C2P has done various POC’s with some of the
large Global Insurers in India , Hong Kong ,
ASIA'S
10
MOST
Rajat Sharma
Founder CEO

Indonesia and Singapore. C2P takes pride in working with
Govt in India and considers it as a remarkable achievement.
It has also partenered Uzbekistan and is in discussion with a
few more ministries to drive public healthcare and ﬁtness
programs.
Most recently the startup was invited by ‘The Translational
Research Institute for Space Health (TRISH)’ to partner as
part of a program run by NASA. Cover2Protect was one of
the ‘TOP 5 startups’ at the IOT congress in 2018 and the
only startups in the healthcare space. It has also been
recognized as one of the ‘Top progressive wellness
companies in Singapore’ by Longevity international UK.
A Bright Future Ahead
Nurturing the next generation of entrepreneurs, the startup
urges them, “if you have an idea to solve a problem in the
healthcare space, GO for IT. There are a lot of problems in
Asia and we will need a lot of entrepreneurs to solve these
problems. There cannot be one organization to solve all
problems, hence we will need many small, specialized
startups to work collaboratively to solve these problems”.
Emphasizing the need for regulations, the organization
advices, “one advice to upcoming entrepreneurs in the
Healthtech space would be ensure that you look at the
regulatory aspects before you start building the platform to
avoid heavy changes and roll backs later in the stage of Go
to market”.
C2P looks for a long term healthcare plan that aims to
create the world’s most intelligent AI platform for
preventive and curative healthcare embracing Ayurveda,
and modern medicine as a holistic approach to healthcare.
Further with its experience C2P is planning to replicate its
eﬀorts in creating the world’s largest network of Ayurveda
(Doctors, dispensaries, nutritionist, Ayurvedic massage, and
wellness packages).
It envisions to provide users worldwide to tap the 5000 year
old power of Ayurveda, and Yoga to deliver wellness
digitally using the comprehensive IOS and Android APPs,
Medical IoT devices, and wearables based in India.
C2P hopes to establish a strong foundation in India by
building a platform that could enable users and healthcare
providers share quality data based on the Realtime
accessible data.
To know more visit, http://www.cover2protect.com/

According to the World Health Organization, nearly
two thirds of the world lack access to diagnostic
imaging. The problem is compounded by three
main challenges: a global shortage of trained radiologists, a
skewed concentration of radiologists in urban vs. rural,
remote areas, and expensive and limited legacy radiology
software (RIS/PACS) that prevent wider usage in emerging
markets.
Technology in healthcare has benefited healthcare
professionals by addressing challenges of access. Radiology
has embraced cloud technology, allowing medical
professionals accessible, more efficient, and cost-effective
solutions. With this innovation, trained radiologists,
although few and concentrated in certain areas, will be able
to work efficiently with a managed inflow of cases from
remote areas, anywhere, anytime.
But technology does not erase the inherent problem brought
about by the scarcity of radiologists. There is a need to train
more radiologists, which, in combination with technological
solutions, may be a more sustainable approach to address
these challenges.
A Singapore-headquartered healthtech enterprise has led
this initiative by providing a simple, elegant, powerful and
intuitive platform for the healthcare ecosystem.
Purpose Linked to the Founder’s Journey
Lack of access to diagnostic imaging and inefficiencies with
current legacy RIS/PACS systems are well-known problems
to Lifetrack’s founder, Dr. Eric Schulze. In 2003, Dr.
Schulze co-founded, 24/7 Radiology, one of the first
teleradiology companies in the United States. It grew to
serve the requirements of 85 sites in the US with radiologist
reading centers in Manila, Singapore, Bangalore, and
Kolkata.
Using the standard radiology software of the time, each
reading center required an on-site data center filled with
multiple rack-mounted blade servers and expensive Cisco
routers and network appliances- representing over
US$100,000 in sunk cost per site. Several full-time IT
personnel had to be employed at each site to ensure reliable
24/7 uptime.
In 2011, Dr. Schulze sold 24/7 Radiology to Alliance
Imaging, a New York Stock Exchange-listed company. He
started Lifetrack Medical Systems and dedicated himself to
rethinking how radiology software could be architected
from the ground up to do truly distributed enterprise
radiology while eliminating all the operational pain and
financial costs he encountered at 24/7 Radiology.
As a practicing radiologist, he was determined to create the
most flexible but efficient platform that radiologists could
use to support any workflow. With the advent of the cloud
and browser era, Dr. Schulze architected the next-
generation LifeSys™ RIS/PACS.
LifeSys: Software with a Mission
To give perspective, in the Philippines, there are only about
LIFETRACK MEDICAL
SYSTEMS
Making Healthcare Software Human

1,000 radiologists catering to the entire country’s
diagnostic imaging needs. That’s 100,000
individuals per radiologist. Even if only around 1/3
of the Philippine’s population (estimated at a total
of 110 million) will ever need just one (1)
diagnostic imaging test in a given year, every
radiologist would have to work 8 hours straight
every day for 360 days averaging only about 6
minutes per study.
This problem is aggravated by the disproportionate
distribution of radiologists in major cities, leaving
smaller cities and especially rural areas and
communities without access. In urban areas, it
usually takes 2-5 working days from the day of
image capture to get a final report. In rural areas, it
can take as long as two weeks, with printed x-ray
films being shipped from one island to the next
where a radiologist is located. Some healthcare
institutions will have a radiologist come only once
a week.
But with the rapid expansion of internet
connectivity, much of what used to be restricted to
clinical settings can now, from a purely technical
perspective, be handled remotely. This includes
diagnostic imaging.
The LifeSys platform enables a distributed
radiology model for an entire provider network
that supports diagnostic healthcare in emerging
markets at a fraction of the cost. Its architecture
allows for rapid transmission, aggregation, and
access of diagnostic images through the cloud
from multiple clinics in remote areas for Lifetrack
partners, using consumer DSL or even 4G.
Using off-the-shelf consumer hardware such as
standard monitors and computers to allow for
affordable adoption in emerging market
environments, offering up to 10x savings in
upfront setup costs is highly compatible with the
LifeSys platform. In resource-constrained
emerging markets, this allows healthcare providers
ASIA'S
10
MOST
Dr. Eric Schulze
We are building a
company worth working
for, with people
worth working with on a
problem worth solving,
and healthcare is a
problem worth solving.”
Eric Schulze, MD PhD,
Chief Executive Officer
“
“

operating in the affordable segment of the market to
upgrade their medical imaging to a fully digital workflow.
This helps them harvest cost savings from removing x-ray
film production, get more productivity out of their
radiologists, and expand to more areas thereby enhancing
access to high-quality medical imaging.
In addition to extending the reach of existing radiologists,
LifeSys was designed to be a cost-effective platform for
radiologist training and capacity building.
LifeSys includes the Active Templates, an advanced
radiology reporting mechanism, and RadNav, a fully-
integrated decision support system, for efficient referencing,
education, and diagnostic standardization. RadNav is
particularly useful in emerging markets where the standard
of specialty training varies and exposure to new modalities
such as CT and MRI may still be limited.
Improving Patient Lives
One of Lifetrack’s partners, the Philippine Tuberculosis
Society (PTSI), a non-profit organization dedicated to the
prevention, control, and treatment of tuberculosis, had to
undergo major renovation for its tuberculosis screening
clinic on the island of Leyte, which had been ravaged by
Typhoon Haiyan a few years previously.
PTSI wanted to upgrade its clinic into a state-of-the-art
modern facility, equipped with a digital x-ray machine. But
with most electrical and telecommunication infrastructure
destroyed by Typhoon Haiyan, they could only send images
using a mobile phone’s 4G connection.
Fortunately, Lifetrack’s LifeSys RIS PACS platform was
architected to accommodate low-bandwidth environments
without compromising image quality and transmission
speed. The clinic is now able to upload diagnostic-grade x-
rays using 4G to the LifeSys cloud server where a
radiologist 900km away is able to access it within five
minutes – cutting the time to diagnosis and treatment of
tuberculosis in a remote, underserved area.
Lifetrack has also improved a customer’s healthcare
outcomes and delivery. Since launching with LifeSys,
FamilyDOC, a chain of community-based primary-care
clinics serving lower middle-class semi-urban areas in the
Philippines, now provides diagnosis within 30 minutes of
an X-Ray. This is a radical improvement on typical waiting
times for x-rays in the Philippines of 2-5 days, saving a
working-class patient from missing one day’s worth of
wages to pick up his report. This is done without any
radiologists on-site.
Diagnostic imaging is done by radiographers on-site and
upload their x-rays to our cloud server using consumer
DSL, where a radiologist working remotely is able to access
it in real-time. This has allowed FamilyDOC to rapidly
scale from an initial two clinics to over 70 clinics in the last
five years.
Awards and Recognition
Lifetrack holds several awards over the past years. In 2016,
Lifetrack was the only Philippine representative to win the
Red Herring Top 100 Asia Award. In 2017, Lifetrack was
awarded in the ASEAN Rice Bowl Startup Awards
Philippines leg as Best Life Sciences/Medtech Startup. In
2018, Lifetrack won the overall award for Excellence in
Disruptive Technologies by the Financial Times
Transformational Business Conference and Awards. Most
recently in 2019, Lifetrack was recognized as one of the
Top 150 Digital Health Startups Redefining Healthcare by
CB Insights.
Future of Lifetrack Medical Systems
Lifetrack aims to be the clear leader in medical imaging for
emerging markets, connecting healthcare institutions,
medical professionals, and patients from Manila to
Marrakech to Medellin. In the next decade we aspire to
have helped diagnose tens of millions of patients, a sizeable
number of which would not have been able to access
medical imaging if not for our technology.
This access to medical imaging becomes key in improving
overall health outcomes for populations in the developing
world, leading to earlier screening of cancer, less invasive
procedures later on, and savings for the healthcare system
as well as longer, healthier lives for people.

HealthcareTHE FUTURE OF AGEING
The world is aging rapidly. What challenges are we
confronted with seeing the expansion of people’s
life span? How will the healthcare industry evolve
and transform to solve these issues? What are the
difficulties that we still need to address during this process?
In the future, the healthcare will shift from post-disease
treatment to daily well-being and disease prevention.
Data generated from Internet of Things (IoT) and
personalized artificial intelligence (AI) will enable a
consumer-driven life care including precision treatment and
chronic disease management. Technologies will be used not
only to improve human's physical health, but also to take
care of our mental health, behavioural health, loneliness and
social isolation.
What are the ageing challenges that we are faced with
today?
The world is getting old in a faster pace than ever.
According to the United Nations, the 60+ population will
more than double from 1 in 7 people in the world to 2 in 7
by 2050, which constitutes a shift from 12% to 22% of the
total population. In China where I live, the Seniors
population will rise to 4 in every 10 people in the total
Chinese population, i.e. 500 million people, further
straining the already overloaded aged care infrastructure in
the country.
However, facing this Silver Tsunami Bombing across the
world, the caregivers that we need for seniors are in great
shortage. Globally, the proportion of younger people who
might be able to provide this care is falling, and women, the
traditional caregivers within many families, are already
filling, or aspiring to, other social and economic roles. As a
result, the assumption that families alone can meet the
needs of older people with significant losses of capacity is
outdated and neither sustainable nor equitable.
Besides, today, most health systems around the world are
un-adapted and ill-prepared to address the needs of seniors,
who often have multiple chronic conditions and live alone
at home. Health services are often designed to cure acute
conditions rather than prevent them, while WHO says that
80% of chronic diseases and 40% of cancers are
preventable.
Meanwhile, people live longer but lonelier. Loneliness
experienced by seniors both affects and is affected by social
activities, solitary leisure activities, physical exercise,
emotional health, self-rated health, and functional
limitations. Early interventions for loneliness are cited as
the key to both preventing social isolation and the
associated health risks.
How can we solve these issues?
Health care industry players should begin taking actions
today with the vision for 2050 in mind. There are many
things that we should do to get there, some of the most
critical actions can be to adopt emerging technologies, and
create now solutions and business models from them.
Real-time health monitoring
Currently, there is no systematic health monitoring
measures in place that bring transparency and awareness to
a senior's health status or provide risk warnings at an early
stage. By the time they visit a hospital, chronic diseases
have often become too advanced and hence challenging to
cure effectively.
The good news is that IoT, electronic devices, and
EXPERT VALUATION

Charles Bark is the Founder CEO of
HiNounou, an AI-Blockchain preventative
digital healthcare platform company on a
mission to help empower the silver generation
toLiveLonger,HealthierandHappier,athome,
and bring greater Peace of Mind to their
families. HiNounou is located in Mainland
China, Hong Kong, Singapore, expanding in
Korea, Japan and Europe. Charles is named
himself by French president Macron as one of
theTop3FrenchentrepreneursinAIinChina.
ABOUT THE AUTHOR
CharlesBark,FounderCEOofHiNounou

Psychological care at stake.
Beyond physiological health, some seniors are suffering
from mental health issues linked to loneliness, depression
and deep grief, leading many of them are turning to suicide.
To reduce their isolation and help them be more involved in
the society, many countries have built elderly communities
and even elderly universities where they can get a sense of
belonging and comfort.
Besides, technologies can also help in various ways.
Sensors can measure their sleep quality and degree stress,
robots can chat and entertain with seniors, social media can
connect friends of same interests with them, etc.
What will we need to think about more?
Having taken look into the above solutions that respond to
the challenge of ageing society, there still remain many
problems that we need to think about more. Here I just list
some of them to start the brainstorming:
An integrated ecosystem rather than a fragmented one.
We notice that current health system tends to manage health
issues in disconnected and fragmented ways that lack
coordination across care providers, settings, time and
location. The leading business models should be based on
holistic solutions that can adapt to the challenges of many
generations to come.
Data privacy and data exchange.
People feel strongly about the right to privacy of their
personal health data. When it comes to technologies, the
suspicion about who will be using the personal data and to
what ends grows. How can we better protect the data and
give transparency to data exchange? The use of Blockchain
might be explored here.
Values from data mining
Although the application of big data analytics in healthcare
fields is promising, it is critical to solve some challenges to
dig out real value from data. An effort to improve the data
quality of electronic health records is necessary. The issues
of data inconsistency and instability, limitations of
observational studies, and validation should be also solved.
wearables are able to gather real-time health data easily in
our daily life. From those data, risk factors can be
identified, some diseases can be detected and interventions
can be implemented at the right time.
For example, HiNounou is offering a dedicated Home
Wellness Kit to seniors, which enable them and their
families to be aware of seniors' health status and prevent
chronic diseases. Some real estate companies are building
assisted living facilities that are equipped with smart
medical devices, sensors, alarms and voice-activated
assistants to take care of older residents.
Accessible and affordable telehealth
Telehealth is gaining momentum these days in China with
the expansion of the coronavirus outbreak. Key players like
PingAn Good Doctor and WeDoctor as well as main
insurance companies are providing 7*24 teleconsultation
for people who are anxious about the coronavirus disease.
No matter in which country, the capacity of hospitals or
clinics can rarely meet the needs of citizens who are living
longer but less healthy. The widespread use of mobile
phones enables the surge of telehealth that grants people
more accessible, affordable and efficient health care
services. Seniors will see doctors at home by phone call or
in front of a screen, a personal health report will be
generated and constantly updated, which can serve as
reference for further medical evaluation and treatments in
hospitals.
Gamification for behaviour and lifestyle changes
Many chronic conditions can be prevented or delayed by
healthy behaviours. Even in very advanced years, physical
activity and good nutrition can have powerful benefits on
health and well-being. Nevertheless, it’s not easy to change
people’s behaviours and lifestyles, that’s why wearables
like Fitbit have been proved as a failure since people
usually don’t wear it for more than six months.
One of the answers to this challenge is incentives through
gamification. For instance, Chinese insurTech company
ZhongAn has designed a product which enables users to
redeem insurance coverage with the number of steps that
they make every day, thus encouraging the users to walk
more and stay active. HiNounou is also using Blockchain
based utility token to reward and incentivize the seniors to
take health check-ups every day.

O
ver the years we have seen how technology has
revolutionized the world and our daily lives. With
the help of technology, some of the greatest minds
were able to put useful information at our fingertips and
even create amazing tools.
All the up and coming and already existing technologies
have paved the way for multi-functional devices like a
smartwatch, smart glasses, 4k TVs, smartphone and many
others. The purpose of all these technologies is to make the
lives of humans better, smarter and seamlessly easy.
The exhaustive reach of technology has some splendid
results in business too. These technologies have not only
helped vendors to stay ahead in the market but also changed
every aspect of the business. Today, aligned with excellent
technology service providers, these vendors are offering
that services to better serve humans and address their
problems.
Adhering to the same, a group of software developers at
Origin Integrated Studios are making a positive difference
by developing innovative and creative healthcare
application software solutions. Let us further read to find
out what inspired the company to do what it does and how
has it successfully established its name in the market.
Charting the Initiation Story
“Software Development is one of the most diverse
sophisticated jobs in the market. Here in Origin Integrated
Studios, we have one of the most passionate and talented
software development team. Together we are making our
mark in the world, developing important, stable and
complex applications solving current industry problems,”
were the first words of Mr. Kenneth Kee, the CEO of the
company.
From its humble beginnings in 2015, when Origin was set
up for Multimedia Super Corridor (MSC) Malaysia Status
by a handful team of software developers in a small office
to the present day, the technical team has grown to over
twenty; the company today has grown in/by leaps and
bounds.
Challenges Along the Way
No success is complete without challenges. Origin
Integrated Studios too had its share of challenges to face.
During the initial days, the company struggled to gain
confidence in the market. Though the company had the best
solutions to offer (compared to 2015 markets), healthcare
vendors were not confident about these solutions. However,
the continuous endeavor of the company is to offer
solutions that catered to all problems. “We had to go low in
terms of pricing, and willing fill the missing requirement
gaps by customization and developing new modules such as
Operation Theatre Module and Chemotherapy Module,”
shares Mr. Kee.
The challenges are no less even today. It faces competition
from both local and foreign solution providers both in terms
of human resources and product differentiation. The
company believes that it is not easy to find local talents that
have both technical skills and domain knowledge required
to provide its services to the clients and to further develop
the products.
However, despite all the company has equipped itself to
offer technical solutions to all type of healthcare
emergencies. It intends to keep up with high demand for the
new opening of hospitals and be ever-ready to digitalize the
healthcare industry in Malaysia.
“Origin started with a vision. Passion brings it alive. Our
team dedication and devotion build customer's loyalty and
continuity. Origin has an intentional purpose to build a
long-lasting great brand that inspires. We never be
ashamed to start small, we never be afraid to dream big,”
comments Mr. Kee.
The Technophile Leading from Front
Mr. Kee embarked on his entrepreneurial journey by
Offering Conclusive Technical Solution For Healthcare

implementing an EMR solution in just one hospital back in 2015. The
company later implemented more than 30 sites in just five years.
Under his leadership, Origin Integrated Studios is on its way to
becoming a household brand of healthcare technology solution
provider for hospital information systems in Malaysia and beyond.
His perseverance, aligned with the passion of all the software
developers, has helped the company bag numerous awards and
recognition.
Pioneering Technical Health Care solutions
Electronic Medical Record or EMR is not a new term in the health
care industry. However, in this age of breakneck
speed, none of the Malaysian companies were to
develop software that offered a comprehensive
healthcare solution. This where Origin stepped in
and developed its application software.
Its flagship product, Origin EMR can be integrated
into any third-party HIS system, or connected
directly to its Origin HIS. This unique positioning
allows its clients to have a choice of implementing
EMR first in their hospital. Origin HIS is a
backend administration process system that
includes administration, security access,
registration, billing, collection refund, stock
inventory, pharmacy, and reporting.
Below are the detail modules and functionalities of
this software include:
• Appointment Scheduling
• Medical Records Management
• Outpatient ER Registration
• Admission, Discharge Transfer
• Accident Emergency Management
• Outpatient (OP) Management
• Inpatient (IP) Bed Management
• Patient Billing, Account Receivable and
Cashiering
• Chemotherapy Module
• Government Tax
• Payor Agreement Staff Benefit
• Charity
• Pharmacy Module (OP, IP OTC)
• Purchasing
• Inventory Management
• Allied Health – Laboratory, Radiology
Physiotherapy/Rehab
• Operating Theatre (OT) Management
• Catheterization Lab Management
• Central Sterile Services Department (CSSD)
• Dietary Management Food Order List for
Kitchen
• Management Dashboard
• Regulatory Submission
• Healthcare Accreditations Complimenting
Features
• Queue Management
• Computerized Physician Order Entry (CPOE)
• Doctors EMR (with type/write/draw/template
clinical notes capturing support)
ASIA'S
10
MOST
Kenneth Kee
CEO
We strongly believe that by
following your passion and by
doing the job you love is the
formula of a successful team
and company
“ “

• Nursing Module
• Document Scanning Management Module
• And other Specialists Modules e.g Dental Eyes
• Integrated Communication System inclusive of SMS,
messaging, email, etc.
• Integration Engine for interfaces with various IT systems
This software has been developed with over 10 years of
industry experience which touts high adoption rates
amongst doctors and nurses. By providing simplistic user
interface designs, Origin EMR allows doctors to either type
or write/draw clinical notes using a lightweight Tablet PC
or notebooks with stylus pen. It also allows to store and
load their favorite templates.
Everything in Origin EMR is template-driven by
Computerized Physician Order Entry (CPOE). It allows
healthcare professions to customize medications, lab, and
radiology orders while connecting with other systems such
as Laboratory Information System (LIS), Radiology
Information System (RIS), Hospital Information System
(HIS), medical equipment and devices such as vital signs
monitor in the hospital together through an HL7
communication protocol. With this in place, the software
also allows professionals to get KPI dashboard reporting of
the hospital’s performance at their fingertips.
The software provides interoperability, efficient clinical
services and better patient safety in many ways:
With CPOE:
• Physician orders are automatically routed to ancillary
services departments for more efficient services
• Improve patient safety by reducing potential human errors
due to traditional manual transcription of doctor orders
With EMR:
• Real time entry and fast access of electronic medical
records
• Improve patient safety through better documentation of
care given
• Provide system generated reports required by insurance or
discharges
• Accessing of patient information with mobile devices
With Nursing module:
• Online nursing documentation for care plan, order
fulfillment, eMAR etc
• Online clinical handover during shift for better safer
care
• Accessing of patient information with mobile devices
With Document Scanning Management module:
• Digitizing and online filing of paper-based clinical
documentation
• Seamless integration with EMR to achieve complete
online patient records
With Reporting module:
• Provide accurate reporting mechanisms to assist
management decision and promote accountability
• Leveraging on the integrated platform for ease of data
collection
• Using configurable graphical dashboard reporting for data
analytics
• Automate accurate reporting
Sketching the Future
From one hospital in 2015, over 30 successful
implementations of 17 hospitals and 13 dialysis clinics in
four years in 2019, Origin is scaled up for new horizons.
With more than ten years of experience in the healthcare
industry and in-depth domain knowledge in hospital
process flow and requirements as well as healthcare
solutions, the company looks forward to remaining at the
forefront as the market leader.
The new technologies as part of product roadmap that the
company has already started integrating to vital signs
monitor with its Early Warning Score (EWS) dashboard,
provide the following benefits:
• Making the clinical workflow more efficient
• Incorporating multimedia features and functionalities that
support telemedicine when it is available
• Integrating with more remote care devices and IoMT
include remote patient monitoring for home nursing
• Data warehousing for group hospitals/clinics to perform
analytics and group reporting
• Instant availability of information in patient portal
Some new modules as part of product roadmap to be
developed are
• Insurance Corporate Claim Management
• Clinical Research
• Mobile App modules e.g Patient Portal
Origin Integrated Studios will also continue providing state-
of-the-art products developed through continuous research
and development, to achieve creative innovations and
solutions.

echnology has made our lives easy. Don’t feel like
Tcooking, get food delivered. Don’t feel like driving
to work, get a cab at your door, and even working
remotely from the comforts of our homes.
Technology has really got our back. Or has it? While the
answer is a big yes, technology has literally got our backs
into pain too. The human body is one giant machine and
like every other good machine, it needs to function
regularly to stay fit. If you leave a machine out-of-work for
long or make it work in stressful situations, it is bound to
rust or breakdown respectively.
Same goes for the human body. Our work is mostly
sedentary and involves devices which hamper our natural
stature leading to issues like back pain, neck pain etc. Those
involved in sports face issues like a muscle pull, ligament
issues and more. Keeping oneself fit and pain-free has
become an arduous task for human beings and a big
opportunity for those who can see it.
The Asian healthcare market, especially that of
Physiotherapy which deals with pain management, is
growing explosively. The affluent societies in Asian
economies are creating greater demands for Quality and
easy access to healthcare facilities. With a sharp focus on
South East Asia market which accounts for about 650
million population, and lacks significant infrastructure for
healthcare Facilities, V2U Healthcare has been spreading
its wings to provide innovative Physiotherapy
Rehabilitation and Electrotherapy equipment.
Managing Pain
V2U’s Physio Asia Therapy Centre in Singapore specializes
in providing back and neck pain management. The
company has its proprietary back pain management
program called ‘SCORES’. This program offers
comprehensive assessment and management of patients
using in-house products and technologies such as – V2U
Trac Pro spinal decompression therapy system for disc
herniated and related problems.
For long term recovery, the team at V2U suggests working
on Core Muscles strengthening techniques. This can be
achieved by using V2U Imaging Ultrasound that targets
specific muscles for strength training along with Achievo
Pressure Biofeedback system to monitor and record the
information on core muscles performance. “Our team
consist of Physiotherapy experts who have years of
experience in managing such patients through this
approach with great success. This Program is available to
other facilities as well as on licensing mechanism,” adds
Dinesh Verma, the Founder and Managing Director.
An Astute Leader
Having trained as a clinical professional physiotherapist,
Dinesh, while working in a clinical capacity with hospitals
in Singapore, noticed a big gap between the Industry and
professionals. He could sense that there was a need for
someone to fill the gap so that the industry and its
technological advancements could make sense to
professionals.
Once he saw the requirement, he took the plunge and
decided to move his career towards product development,
management and business development. The first step
towards it was to prepare himself academically and in terms
of soft skills including managerial ones. So, in the early 90s
he pursued part-time studies in Business Administration and
later completed an MBA from Henley Management College
in 1999. Once equipped with the necessary skills, he
ventured into business by taking a job as Product Manager
with Singapore Medical Device distribution company in
1997 and later in 2002, established his first company in
partnership with his past employer.
As the Founder and Managing Director of V2U Healthcare,
Dinesh has established the company’s vision and mission
and worked on crafting strategies to fulfil desired outcomes.
He always wanted to create a difference by being a Solution
Provider and not merely a distributor of physiotherapy
products. Hence he, along with his team, emphasized on
careful technology selection; invested in employee learning
and educating the customer. To remain relevant, he
established V2U’s clinical services in Physiotherapy in
2006 – Physio Asia Therapy Centre. This also provided as a
V2U HEALTHCARESetting Benchmarks in Physiotherapy and Rehabilitation Care

test-bed for the company’s technologies and concepts.
A Growing Industry with Promising Opportunities
The Physiotherapy and Rehab Medicine market is still at the infancy
stage in most of the Asian country and that provides great growth
opportunity, not without challenges. The market players are
constantly challenged by emerging competition and technologies. As
an entrepreneur, Dinesh feels that healthy competition helps in
growing the market. Healthcare and especially rehabilitation
medicine market is huge and still underdeveloped and a healthy
competition is a healthy sign for market
development. He also states that V2U is aware of
and equipped with new technologies, and
unhesitatingly approaches development.
As someone who believes in the famous quote
“Winners don’t do different things, they do things
differently,” Dinesh is always on the lookout for
advancements and is more than happy to adopt
new methods and technologies in V2U’s portfolio
as long as they meet the company’s screening
criteria. He feels that those who can manage their
resources effectively and efficiently will emerge as
the winner.
Miles to Go
Dinesh and his team’s winning attitude has been
lauded at several platforms. In 2011 Dinesh was
awarded the Most Promising Entrepreneur Award
by Asia Pacific Entrepreneurship Awards. In 2014,
he won the Physio Ratna – Highest Award honour
given to one physiotherapist each year by Indian
Association of Physiotherapists.
In 2018, Singapore Prestige Brand Award 2018
was given to V2U for Physio Asia Therapy Centre
– Singapore. More recently, in 2019 Dinesh was
awarded the Singapore Indian Chamber of
Commerce Entrepreneur Awards in Promising
Enterprise category. These are just a few of the
many accolades.
Additionally, V2U Healthcare, as a company, has
accomplished ISO 13485 certification and also
received Singapore Quality Class and Singapore
Service Class certifications. V2U has positioned
itself to take on the S-E Asian markets for its
growth needs. It has invested in establishing its
subsidiaries in key countries – Singapore,
Malaysia, Thailand, Vietnam and the Philippines.
V2U is moving with a strategy to vertically
integrate its business – at one end it is developing
and introducing Own Brand value-added products
and at another end, it is planning to invest in its
Own Centre of Physiotherapy – currently in
Singapore and Manila and planned for 2020 in
Kuala Lumpur. Having a vertically integrated
approach in a niche market will be the key to
success for V2U in future.
ASIA'S
10
MOST
Dinesh Verma
Founder
Managing Director
We envision becoming
a leading rehabilitation
medicine, healthcare
wellness industry
solution provider in
Singapore and Asia.
“
“

Most Pioneering Healthcare Solution Providers | Thyrocare

Most Pioneering Healthcare Solution Providers | Thyrocare

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Most Pioneering Healthcare Solution Providers | Thyrocare

Similar to Most Pioneering Healthcare Solution Providers | Thyrocare (20)

More from insightscare

More from insightscare (20)

Recently uploaded

Recently uploaded (20)

Most Pioneering Healthcare Solution Providers | Thyrocare